VRNA

Verona Pharma
VRNA

Overview Fund Activity

13 hedge funds and large institutions have $26.8M invested in Verona Pharma in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
–
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WS
1
Wedbush Securities
California
$139K
2
IWM
2
IHT Wealth Management
Illinois
$94K

Top Sellers

1
VC
1
Vivo Capital
California
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
Deutsche Bank
3
Deutsche Bank
Germany
$1K
4
OSNBOA
4
Old Second National Bank of Aurora
Illinois
$0
5
UBS Group
5
UBS Group
Switzerland
$5K
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$5.71M 1,250,396 – –
NMC
2
NEA Management Company
Maryland
$5.57M 1,219,674 – –
A
3
Abingworth
United Kingdom
$4.12M 901,943 – –
VP
4
venBio Partners
California
$4M 875,000 – –
NHAS
5
Novo Holdings A/S
Denmark
$3.39M 740,740 – –
ACM
6
Aisling Capital Management
New York
$2.03M 443,596 – –
TCM
7
Tekla Capital Management
Massachusetts
$1.26M 275,000 – –
PC
8
Polar Capital
United Kingdom
$457K 100,000 – –
WS
9
Wedbush Securities
California
$139K 30,315 +6,000 +25%
IWM
10
IHT Wealth Management
Illinois
$94K 20,460 +3,130 +18%
US Bancorp
11
US Bancorp
Minnesota
$18K 3,840 – –
UBS Group
12
UBS Group
Switzerland
$5K 1,115 -272 -20%
Deutsche Bank
13
Deutsche Bank
Germany
$1K 374 -9,900 -96%
VC
14
Vivo Capital
California
– – -1,492,951 Closed
Renaissance Technologies
15
Renaissance Technologies
New York
– – -10,300 Closed
OSNBOA
16
Old Second National Bank of Aurora
Illinois
– – -1,481 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– – -262 Closed
CFGS
18
Concourse Financial Group Securities
Alabama
– – – –